A roadmap for psychedelic pharmacy in Canada
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Psychedelics and Philosophy
Decriminalisation of drug possession in Oregon: Analysis and early lessons
Working with Drug Science
Teaching the future generations about drugs
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
Why do drugs have so much stigma?
Creating better teaching resources for secondary school drug education
Taking matters into my own hands: Self-taught drug education
The Drug Science podcast returns with two new co-hosts!
No Laughing Matter: The Nonsense Plan to Criminalise Nitrous Oxide
Preliminary findings from T21 Australia
Combating the stigma: a T21 success story
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in T21
Drug Science submits evidence to the ACMD Nitrous Oxide Review
Grow Pharma joins T21
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
Psychedelics for managing pain
Drug Science’s medical cannabis patient registry (T21) sees departure of Lyphe Group and introduces new pricing model
Response from Drug Science to the Australian Government consultation on potential reforms to the regulation of nicotine vaping products
Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year
Neuroplasticity in Mental Health Recovery: Prompting the Brain to Cure Itself
Catch up on the UK Patient Conference
Busting the Myths Surrounding Psychedelics